bioAffinity Technologies, Inc.
BIAF
$0.4698
-$0.0292-5.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.02% | 12.66% | -21.27% | -27.99% | -41.72% |
| Total Depreciation and Amortization | 3.23% | 162.67% | 599.54% | 589.40% | 1,938.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.17% | -0.38% | 68.06% | 80.01% | 537.23% |
| Change in Net Operating Assets | 141.43% | -108.83% | -25.37% | -365.81% | 51.19% |
| Cash from Operations | -3.77% | -11.53% | -12.68% | -53.43% | -24.27% |
| Capital Expenditure | -100.00% | -4,600.00% | -625.64% | -28.17% | 106.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | 99.57% | -625.64% | -28.17% | 106.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.31% | -79.13% | 28.31% | -6.48% | 84.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,489.03% | 3,395.08% | 27.76% | 2,523.77% | 84.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 120.66% | 98.81% | -10.87% | 77.60% | 19.02% |